Predict your next investment

Merus Labs - Canadian Assets

HEALTHCARE | Pharmaceuticals / Drugs

See what CB Insights has to offer

Stage

Acquired Unit | Acquired

About Merus Labs - Canadian Assets

Merus Labs is a specialty pharmaceutical company with products for oncology, women's health, cardiovascular diseases, urology, and infectious diseases.

Merus Labs - Canadian Assets Headquarter Location

100 Wellington Street West Suite 2110

Toronto, Ontario, M5K 1H1,

Canada

416-593-3725

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.